Rockwell Medical (NASDAQ:RMTI) Now Covered by Analysts at Rodman & Renshaw

Rodman & Renshaw started coverage on shares of Rockwell Medical (NASDAQ:RMTI) in a research note released on Thursday morning, MarketBeat reports. The firm issued a buy rating and a $5.00 price objective on the stock.

Other analysts have also issued research reports about the stock. HC Wainwright restated a “buy” rating and issued a $9.00 price target on shares of Rockwell Medical in a research note on Wednesday, September 11th. StockNews.com upgraded shares of Rockwell Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 13th.

Rockwell Medical Stock Down 5.2 %

Shares of NASDAQ:RMTI opened at $2.36 on Thursday. The company has a current ratio of 2.41, a quick ratio of 1.60 and a debt-to-equity ratio of 0.33. The company has a fifty day simple moving average of $3.68 and a 200 day simple moving average of $2.62. The firm has a market cap of $76.28 million, a PE ratio of -47.10 and a beta of 1.50. Rockwell Medical has a 12-month low of $1.16 and a 12-month high of $5.15.

Hedge Funds Weigh In On Rockwell Medical

Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in shares of Rockwell Medical by 4.0% during the first quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company’s stock valued at $1,856,000 after acquiring an additional 43,302 shares during the period. Armistice Capital LLC boosted its holdings in shares of Rockwell Medical by 22.5% during the second quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock valued at $5,670,000 after acquiring an additional 592,000 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of Rockwell Medical by 877.1% during the second quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock valued at $181,000 after acquiring an additional 92,189 shares during the period. Beacon Financial Advisory LLC acquired a new position in shares of Rockwell Medical during the third quarter valued at $98,000. Finally, Verus Capital Partners LLC acquired a new stake in Rockwell Medical in the third quarter worth about $51,000. Institutional investors and hedge funds own 23.31% of the company’s stock.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.